BFSG LLC’s Moderna MRNA Stock Holding History

BFSG LLC’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82K	Buy	+26	New	+$1.34K	﹤0.01%	700
2025 Q3	–	Sell	-79	Closed	-$2.18K	–	718
2025 Q2	$2.18K	Hold	79	–	–	﹤0.01%	605
2025 Q1	$2.24K	Buy	79 +59	+295%	+$2.09K	﹤0.01%	600
2024 Q4	$832	Hold	20	–	–	﹤0.01%	634
2024 Q3	$1.34K	Hold	20	–	–	﹤0.01%	598
2024 Q2	$2.38K	Hold	20	–	–	﹤0.01%	570
2024 Q1	$2.13K	Hold	20	–	–	﹤0.01%	588
2023 Q4	$1.99K	Buy	+20	New	+$1.68K	﹤0.01%	544
2021 Q4	–	Sell	-3,954	Closed	-$1.52M	–	228
2021 Q3	$1.52M	Buy	+3,954	New	+$1.46M	0.23%	114
2020 Q3	–	Sell	-9,508	Closed	-$611K	–	195
2020 Q2	$611K	Buy	+9,508	New	+$521K	0.13%	122

Other funds holding MRNA

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

LAI

Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

BFSG LLC's MRNA Position: Q2 2026 in Review

BFSG LLC opened a new position in Moderna (MRNA) in Q2 2026: 26 shares worth $1.82K. The stake represents ﹤0.01% of the portfolio and ranks #700 among its holdings. This is a return to the name: BFSG LLC previously reported a position in MRNA as recently as Q2 2025.

BFSG LLC first reported a position in MRNA in Q2 2020 and has held it in 10 quarters since. The position peaked at $1.52M in Q3 2021. 112 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

BFSG LLC held 26 shares of Moderna worth $1.82K as of Q2 2026.
Moderna was a new BFSG LLC position in Q2 2026.
Moderna made up ﹤0.01% of BFSG LLC's portfolio in Q2 2026, its #700 holding.
BFSG LLC first reported a position in Moderna in Q2 2020 and has held it in 10 quarters since.
BFSG LLC's Moderna position peaked at $1.52M in Q3 2021.
112 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.